Prev Chronic Dis by Liu, Yong et al.
PREVENTING  CHRONIC  DISEASE
P U B L I C  H E A L T H  R E S E A R C H ,  P R A C T I C E ,  A N D  P O L I C Y 
  Volume 16, E93                                                                         JULY 2019  
 
ORIGINAL RESEARCH
 
 
Chronic Obstructive Pulmonary Disease and
Arthritis Among US Adults, 2016
 
Yong Liu, MD, MS1; Anne G. Wheaton, PhD1; Louise B. Murphy, PhD1; Fang Xu, PhD1;
Janet B. Croft, PhD1; Kurt J. Greenlund, PhD1
 
Accessible Version: www.cdc.gov/pcd/issues/2019/19_0035.htm
Suggested  citation  for  this  article:  Liu Y,  Wheaton AG,
Murphy LB, Xu F, Croft JB, Greenlund KJ. Chronic Obstructive
Pulmonary Disease and Arthritis Among US Adults, 2016. Prev
Chronic  Dis  2019;16:190035.  DOI:  https://doi.org/10.5888/
pcd16.190035.
PEER REVIEWED
Summary
What is already known on this topic?
More than 54 million US adults report having arthritis, and more than 15
million US adults report having chronic obstructive pulmonary disease.
What is added by this report?
Adults with arthritis are more likely than adults without arthritis to have a
higher prevalence of COPD (13.7% vs 3.8%). The relationships remained
significant among all subgroups of selected characteristics after we con-
trolled for covariates.
What are the implications for public health practice?
Assessment of COPD and arthritis symptoms by health care providers may
enhance earlier detection of each condition. Evidence-based self-
management programs may ameliorate symptoms.
Abstract
Introduction
More than 54 million US adults have arthritis, and more than 15
million US adults have chronic obstructive pulmonary disease
(COPD). Arthritis and COPD share many risk factors, such as to-
bacco use, asthma history, and age. The objective of this study
was to assess the relationship between self-reported physician-dia-
gnosed COPD and arthritis in the US adult population.
Methods
We analyzed data from 408,774 respondents aged 18 or older in
the 2016 Behavioral Risk Factor Surveillance System to assess the
association between self-reported physician-diagnosed COPD and
arthritis in the US adult population by using multivariable logistic
regression analyses.
Results
Overall crude prevalence was 6.4% for COPD and 25.2% for arth-
ritis. The prevalence of age-adjusted COPD was higher among re-
spondents with arthritis than among respondents without arthritis
(13.7% vs 3.8%, P < .001). The association remained significant
among most subgroups (P < .001) particularly among adults aged
18 to 44 (11.5% vs 2.0%) and never smokers (7.6% vs 1.7%). In
multivariable logistic regression analyses, arthritis status was sig-
nificantly associated with COPD status after controlling for so-
ciodemographic characteristics, risk behaviors, and health-related
quality of life measures (adjusted prevalence ratio = 1.5, 95% con-
fidence interval, 1.4–1.5, P < .001).
Conclusion
Our results confirmed that arthritis is associated with a higher pre-
valence of COPD in the US adult population. Health care pro-
viders may assess COPD and arthritis symptoms for earlier detec-
tion of each condition and recommend that patients with COPD
and/or arthritis participate in pulmonary rehabilitation and self-
management  education programs such as  the Chronic Disease
Self-Management Program, the proven benefits of which include
increased aerobic activity and reduced shortness of breath, pain,
and depression.
Introduction
More than 15 million US adults have chronic obstructive pulmon-
ary disease (COPD), and more than 54 million US adults have
arthritis (1,2). COPD is characterized by progressive, irreversible
airflow limitation and was the fourth leading cause of death in the
United States in 2016 (3). Arthritis is a common chronic condi-
tion and a leading cause of disability (4). Data from cross-section-
al  studies suggest  that  adults  with COPD are more likely than
adults without COPD to have arthritis (5), including osteoarthritis
(6) and rheumatoid arthritis (7). Emerging evidence from longitud-
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inal studies also shows a higher risk of developing COPD among
adults with arthritis than adults without arthritis at baseline (8–11).
COPD and arthritis share many of the same risk factors, such as
sex, age, lower socioeconomic status, tobacco use, obesity, and in-
fection (12–14). Most previous studies assessed the COPD–arthrit-
is  relationship  by  controlling  for  those  common  risk  factors
(9–11). However, few studies, including nationally representative
studies,  examined  the  relationship  among  subgroups  with  or
without those risk factors (5,11). Describing these relationships
may inform health care providers to assess COPD and arthritis
symptoms for earlier detection of these conditions and provide
new insights into preventing them.
The objective of this study was to assess the relationship between
self-reported physician-diagnosed COPD and arthritis in the US
adult population aged 18 or older in the 2016 Behavioral Risk
Factor Surveillance System (BRFSS). We examined the relation-
ship among subgroups with and without the common risk factors.
Methods
The BRFSS is a random-digital–dialed landline and cellular tele-
phone survey that is conducted by state health departments in col-
laboration with the Centers for Disease Control and Prevention
(CDC) in all 50 states, the District of Columbia, and US territor-
ies  (www.cdc.gov/brfss).  The  BRFSS  collected  data  on  so-
ciodemographic characteristics, health-related behaviors, chronic
diseases, and other conditions among the adult population (aged
≥18) in 2016. Disproportionate stratified sampling of respondents
defined by race/ethnicity, sex, or age may vary between states.
CDC weighted each sample using design weighting and “raking”
weighting methods to obtain a study population representative of
each state. Trained interviewers administered standardized ques-
tionnaires to all adult respondents. All respondents provided an or-
al consent statement for participating in the survey. The study was
approved as exempt research by CDC’s institutional review board.
Measures
Respondents who answered yes to the question of whether they
had ever been told by a doctor, nurse, or other health professional
that they had “chronic obstructive pulmonary disease (COPD),
emphysema, or chronic bronchitis” or arthritis (“some form of
arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia”) were
determined to have those conditions. Asthma status, a covariable
in this study, was based on questions about whether respondents
had ever been told they had asthma and “still have asthma.” We
categorized responses as current asthma, history of asthma only, or
no asthma.
 
Other covariates were age groups (18–44, 45–64, 65–74, and ≥75
y), sex, race/ethnicity (non-Hispanic white, non-Hispanic black,
Hispanic, American Indian/Alaska Native, Asian, and non-Hispan-
ic other), education levels (<high school diploma, high school dip-
loma or GED, some college, and college graduate), and employ-
ment status (employed, unemployed, retired, unable to work, and
other). Sleep duration was defined according to a response to the
question, “On average, how many hours of sleep do you get in a
24-hour period?” We defined short sleep duration as fewer than 7
hours of sleep (15). The number of physically unhealthy days was
determined according to the question, “Now thinking about your
physical health, which includes physical illness and injury, for
how many days during the past 30 days was your physical health
not good?” The number of mentally unhealthy days was determ-
ined according to the question, “Now thinking about your mental
health, which includes stress, depression, and problems with emo-
tions, for how many days during the past 30 days was your mental
health not good?” Consistent with previous research (16),  fre-
quent physical distress was defined as 14 or more physically un-
healthy days, and frequent mental distress was defined as 14 or
more mentally unhealthy days. Any leisure-time physical activity
was  defined  according  to  a  yes  response  to  a  single  question,
“During the past month, other than your regular job, did you parti-
cipate in any physical activities or exercises such as running, calis-
thenics, golf, gardening, or walking for exercise?” Smoking status
was defined by 2 questions: “Have you smoked at least 100 cigar-
ettes in your entire life?” and “Do you currently smoke every day,
some days, or not at all?” Respondents were current smokers if
they reported having smoked at least 100 cigarettes during their
lifetime and currently smoked every day or some days. Former
smokers were defined as respondents who reported having smoked
at least 100 cigarettes during their lifetime but did not currently
smoke. Never smokers were defined as respondents who reported
not having smoked at least 100 cigarettes during their lifetime.
Body mass index (BMI, kg/m2) was calculated from self-reported
height and weight and categorized as underweight (BMI < 18.5),
normal weight (BMI = 18.5–24.9), overweight (BMI = 25.0–29.9),
or obese (BMI ≥ 30.0). Excessive alcohol drinkers were defined as
respondents who had any alcohol drinks and were younger than
21, women who were pregnant and reported drinking any alcohol
in the previous month, or respondents who were binge drinkers
(≥5 drinks for men on an occasion and ≥4 drinks for women on an
occasion) or heavy drinkers (≥15 drinks per week for men and ≥8
drinks per week for women during the past 30 days) (17).
In  2016,  486,303 respondents  aged 18 or  older  residing in  50
states, Washington, DC, and the US territories participated in the
survey. The median response rate was 47.1% (range, 30.7% in
Louisiana to  65.0% in Wyoming) (18).  After  we excluded re-
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spondents with missing values (age [n = 6,697], COPD [n = 156],
arthritis [n = 99], or risk behaviors and health-related quality of
life [n = 70,577]), we analyzed complete data for 408,774 adult re-
spondents.
Statistical analysis
We calculated the age-adjusted prevalence of COPD and 95%
confidence intervals (CIs) by standardizing to the 2000 projected
US population in 5 age groups (18–24, 25–34, 35–44, 45–64, and
≥ 65) by arthritis status and selected characteristics (19). We per-
formed multivariable logistic regression analyses to assess the as-
sociation of COPD with arthritis after controlling for age, sex,
race/ethnicity, education levels, employment status, short sleep
duration,  frequent  mental  distress,  frequent  physical  distress,
smoking status, BMI category, leisure-time physical activity, ex-
cessive alcohol drinking, and asthma status. We conducted all ana-
lyses in SAS–callable SUDAAN version 11.0.1 (Research Tri-
angle Institute) to account for the complex sampling design. We
determined significant differences at P < .05.
Results
Respondents  with  arthritis  were  more  likely  than respondents
without arthritis to be women, aged 45 or older,  non-Hispanic
white, and not a college graduate, to be retired or unable to work,
to have frequent mental or physical distress, to be former or cur-
rent smokers, to have short sleep duration, to be obese, and to have
current asthma or a history of COPD. Respondents with arthritis
were less likely than respondents without arthritis to report excess-
ive alcohol drinking or leisure-time physical activity (P < .001)
(Table 1).
The crude prevalence of COPD and arthritis was 6.4% and 25.2%,
respectively, among US adults in 2016. Respondents with arthritis
had a  higher  age-adjusted COPD prevalence than respondents
without arthritis overall (13.7% vs 3.8%, P < .001) (Table 2). In
subgroup analyses, we observed a higher prevalence of COPD and
arthritis with increasing age (Figure 1).
Figure  1.  Age-specific  percentage  of  self-reported  chronic  obstructive
pulmonary disease (COPD) and arthritis among US adults aged ≥18, 2016
Behavioral  Risk Factor  Surveillance System. Error  bars indicate standard
errors.
 
The age-adjusted prevalence of COPD was higher among respond-
ents with arthritis than among respondents without arthritis, re-
gardless of sex, age group, education level, employment status,
frequent mental distress, frequent physical distress, leisure-time
physical activity, smoking status, short sleep duration, BMI cat-
egory, excessive alcohol drinking, and asthma status (P < .001)
(Table  2).  The  age-adjusted  prevalence  of  COPD was  higher
among respondents with arthritis than among respondents without
arthritis in most racial/ethnic groups (P < .001). Although the pre-
valence of COPD was low in some subgroups (eg, younger adults,
college graduates, and respondents who never smoked), respond-
ents with arthritis were significantly more likely than respondents
without arthritis to report COPD in these subgroups. For example,
among adults aged 18 to 44, the age-adjusted prevalence of COPD
was 11.5% for respondents with arthritis and 2.0% for respond-
ents without arthritis (Figure 2).
Figure 2. Age-specific prevalence of chronic obstructive pulmonary disease
(COPD) among US adults aged ≥18 years, by arthritis status, 2016 Behavioral
Risk Factor Surveillance System. Error bars indicate standard errors.
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Among never smokers, the prevalence of COPD was 7.6% for re-
spondents with arthritis and 1.7% for respondents without arthritis
(Figure 3).
Figure 3. Age-adjusted prevalence of chronic obstructive pulmonary disease
(COPD) among US adults aged ≥18 years, by smoking status and arthritis,
2016  Behavioral  Risk  Factor  Surveillance  System.  Error  bars  indicate
standard errors.
 
In multivariable logistic regression analyses, arthritis was signific-
antly  associated with  COPD, after  controlling for  sociodemo-
graphics, risk behaviors, frequent mental distress, frequent physic-
al distress, and asthma status (adjusted prevalence ratio = 1.5, 95%
confidence interval, 1.4–1.5; P < .001) (Table 2). The association
remained statistically significant among most subgroups by selec-
ted characteristics, including adults aged 18 to 44 and nonsmokers.
Discussion
Our study demonstrated that the prevalence of COPD was almost
50% higher among adults with arthritis than among adults without
arthritis in the United States after adjustment for sociodemograph-
ic characteristics,  risk behaviors, frequent mental distress, fre-
quent physical distress, and asthma status. Additionally, the rela-
tionship between COPD and arthritis was evident in essentially all
subgroups of sociodemographic characteristics,  risk behaviors,
frequent mental distress, frequent physical distress, and a history
of asthma. Our results, from a large nationwide sample, are con-
sistent with the results of previous hospitalization and clinical
studies of the association between COPD and osteoarthritis  or
rheumatoid arthritis (5–11). Those previous studies showed only
the association between COPD and arthritis in sex and age groups
(5,7,8,10,11). Therefore, our results add epidemiological informa-
tion to the existing literature.
The reason for a positive association between COPD and arthritis
is not clear. First, prolonged systemic inflammation may mediate
the relationship between arthritis and COPD (8). Second, smoking
is a common risk factor for both arthritis and COPD, and it may
exacerbate  the  2  underlying  conditions  (20,21).  Therefore,
smoking cessation is important to preventing and managing arth-
ritis and COPD. Third, stiff joints and joint pain, weak muscles,
and poor balance are common symptoms of arthritis. These symp-
toms can limit a person’s physical activity and further impair res-
piratory function in people who also have COPD. Conversely,
dyspnea or shortness of breath are common symptoms of COPD
and can make arthritis worse if patients become more sedentary
(22). Therefore, physical inactivity may contribute to the relation-
ship between COPD and arthritis. However, aerobic activity could
reduce symptoms of both COPD and arthritis (22,23). Therefore,
aerobic physical activity interventions or pulmonary rehabilitation
may improve long-term health outcomes for patients with COPD
and/or arthritis (22,23). Finally, follow-up care and treatment of
one condition may lead health care providers to detect and dia-
gnose comorbid conditions.
Our study showed that the greater prevalence of COPD among
adults with arthritis than among adults without arthritis remained
significant among all subgroups by selected characteristics in mul-
tivariable logistic regression models including sociodemographics,
risk behaviors, frequent mental distress, frequent physical distress,
and  asthma  status.  It  also  demonstrated  that  the  relationship
between COPD and arthritis  was not  only among people  with
common risk factors but also among younger adults and among
nonsmokers. Our findings imply that assessment of COPD and
arthritis symptoms by a primary care physician might be advised
for persons with arthritis or COPD.
Health care providers may also consider referring their patients to
evidence-based self-management education programs, such as the
Chronic  Disease Self-Management  Program (CDSMP),  which
were  developed  to  help  people  with  chronic  diseases  such  as
COPD and arthritis manage their symptoms and improve their
quality of life (24). A meta-analysis showed that people participat-
ing in CDSMP experienced numerous benefits, including reduced
shortness of breath, pain, and depression and increased aerobic
activity (25).
Our study had several limitations. First, because BRFSS is a cross-
sectional survey, we cannot make causal inferences. Second, arth-
ritis was defined as a broad category that included rheumatoid
arthritis, gout, lupus, fibromyalgia, or any other form of arthritis.
There are more than 100 types of arthritis (26), and our results
may  not  apply  to  all  types.  Further  research  on  associations
between COPD and various types of arthritis may reveal more in-
sights into the relationship. Third, sample selection bias due to low
response rates may have also influenced our results. However, the
effect of potential systematic bias was likely limited because the
relationship between COPD and arthritis in our study is consistent
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with the relationship described in previous studies (5,8). Finally,
all responses to survey questions in the study were self-reported;
as such, they were subject to recall bias, and this bias might have
affected our results.
Our results confirmed that arthritis was associated with a higher
likelihood of COPD in the US adult population. Health care pro-
viders may assess COPD and arthritis symptoms for earlier detec-
tion and recommend to their patients with COPD and/or arthritis
to participate in evidence-based self-management education pro-
grams such as the Chronic Disease Self-Management Program to
manage their symptoms, including shortness of breath, pain, and
depression, and improve their quality of life.
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Tables
Table 1. Distribution of Selected Characteristics Among Adults Aged ≥18, by Arthritis Status, Behavioral Risk Factor Surveillance System, 2016
Characteristic Na
Weighted % (95% CI)
Has Arthritis (n = 141,752) Does Not Have Arthritis (n = 267,022)
Sex
Men 184,406 42.8 (42.3–43.4) 53.1 (52.7–53.5)
Women 224,368 57.2 (56.6–57.7) 46.9 (46.5–47.3)
Age group, y
18–44 109,778 15.1 (14.7–15.6) 56.8 (56.4–57.1)
45–64 154,671 43.8 (43.3–44.4) 30.3 (30.0–30.7)
65–74 85,432 23.1 (22.6–23.5) 8.1 (8.0–8.3)
≥75 58,893 18.0 (17.6–18.4) 4.8 (4.6–4.9)
Race/ethnicity
Non-Hispanic white 319,061 74.4 (73.9–75.0) 61.6 (61.2–61.9)
Non-Hispanic black 32,189 10.8 (10.4–11.2) 11.6 (11.4–11.9)
Hispanic 31,705 9.6 (9.2–10.0) 17.9 (17.6–18.3)
American Indian/Alaska Native 5,961 1.1 (1.0–1.2) 0.9 (0.8–0.9)
Asian 8,768 2.1 (1.8–2.5) 6.0 (5.8–6.3)
Non-Hispanic other 11,090 2.0 (1.8–2.1) 2.0 (1.9–2.1)
Education level
<High school diploma 28,645 15.6 (15.1–16.1) 11.6 (11.3–11.9)
High school diploma or GED 113,502 30.2 (29.8–30.7) 27.3 (27.0–27.7)
Some college 112,976 32.6 (32.1–33.2) 31.4 (31.0–31.7)
College graduate 153,132 21.5 (21.2–21.9) 29.7 (29.4–30.0)
Employment status
Employed 204,591 36.5 (36.0–37.1) 65.4 (65.0–65.7)
Unemployed 15,860 4.5 (4.2–4.7) 5.4 (5.2–5.6)
Retired 125,176 36.7 (36.2–37.2) 11.9 (11.7–12.1)
Unable to work 29,143 15.6 (15.2–16.0) 3.6 (3.4–3.7)
Other 32,279 6.7 (6.4–7.0) 13.8 (13.5–14.1)
Frequent mental distress
Yes 43,085 17.6 (17.2–18.1) 9.6 (9.4–9.9)
No 365,689 82.4 (81.9–82.8) 90.4 (90.1–90.6)
Frequent physical distress
Yes 55,210 26.6 (26.1–27.1) 6.9 (6.7–7.1)
No 353,564 73.4 (72.9–73.9) 93.1 (92.9–93.3)
Abbreviations: BMI, body mass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease.
a The final unweighted sample size (n = 408,774) was obtained from 486,303 interviewed adults aged ≥18 year and excluded respondents with a missing value
for age, COPD, arthritis, risk behaviors, or health-related quality of life. Categories might not sum to the sample total because of missing responses.
(continued on next page)
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Table 1. Distribution of Selected Characteristics Among Adults Aged ≥18, by Arthritis Status, Behavioral Risk Factor Surveillance System, 2016
Characteristic Na
Weighted % (95% CI)
Has Arthritis (n = 141,752) Does Not Have Arthritis (n = 267,022)
Leisure-time physical activity in the past 30 days
Yes 309,114 66.7 (66.1–67.2) 80.1 (79.8–80.5)
No 99,660 33.3 (32.8–33.9) 19.9 (19.5–20.2)
Smoking status
Current smokers 61,266 19.3 (18.8–19.7) 15.7 (15.4–15.9)
Former smokers 119,165 34.7 (34.2–35.2) 21.4 (21.1–21.7)
Never smoked 228,343 46.0 (45.5–46.6) 62.9 (62.6–63.3)
Short sleep duration (<7 hours in 24-hour period)
Yes 129,697 39.6 (39.1–40.1) 32.9 (32.6–33.3)
No 279,077 60.4 (59.9–60.9) 67.1 (66.7–67.4)
BMI, kg/m2
Underweight (<18.5) 6,586 1.4 (1.3–1.6) 2.1 (1.9–2.2)
Normal weight (18.5–24.9) 129,712 24.2 (23.7–24.7) 36.2 (35.8–36.6)
Overweight (25.0–29.9) 147,838 34.1 (33.6–34.7) 35.6 (35.3–36.0)
Obese (≥30.0) 124,638 40.2 (39.7–40.7) 26.1 (25.8–26.4)
Excessive alcohol drinking
Yes 135,738 28.3 (27.8–28.8) 41.0 (40.6–41.4)
No 266,787 71.7 (71.2–72.2) 59.0 (58.6–59.4)
Asthma status
Current asthma 37,667 14.4 (14.0–14.8) 7.0 (6.8–7.2)
History of asthma only 15,995 4.6 (4.4–4.9) 4.5 (4.4–4.7)
No asthma 355,112 81.0 (80.5–81.4) 88.5 (88.2–88.7)
Has COPD
Yes 33,421 14.8 (14.4–15.2) 3.5 (3.4–3.7)
No 375,353 85.2 (84.8–85.6) 96.5 (96.3–96.6)
Abbreviations: BMI, body mass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease.
a The final unweighted sample size (n = 408,774) was obtained from 486,303 interviewed adults aged ≥18 year and excluded respondents with a missing value
for age, COPD, arthritis, risk behaviors, or health-related quality of life. Categories might not sum to the sample total because of missing responses.
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Table 2. Age-Adjusted Prevalence and Adjusted Prevalence Ratio of COPD Among Adults Aged ≥18, by Arthritis Status and Selected Characteristics, Behavioral Risk
Factor Surveillance System, 2016a
Characteristic Has Arthritis, % (95% CI)b
Does Not Have Arthritis, % (95%
CI)b
Adjusted Prevalence Ratio (95%
CI)c
Total 13.7 (13.1–14.4) 3.8 (3.7–3.9) 1.5 (1.4–1.5)
Sex
Men 12.7 (11.8–13.7) 3.7 (3.5–3.9) 1.5 (1.4–1.6)
Women 14.4 (13.7–15.3) 3.9 (3.8–4.1) 1.4 (1.3–1.5)
Age group, y
18–44 11.5 (10.5–12.7) 2.0 (1.9–2.2) 2.2 (1.9–2.5)
45–64 15.6 (15.0–16.2) 4.2 (3.9–4.5) 1.5 (1.4–1.6)
65–74 15.3 (14.6–16.1) 8.1 (7.5–8.6) 1.3 (1.2–1.4)
≥75 15.1 (14.2–16.1) 9.4 (8.7–10.1) 1.2 (1.1–1.3)
Race/ethnicity
Non-Hispanic white 13.5 (12.8–14.2) 4.1 (3.9–4.2) 1.4 (1.3–1.5)
Non-Hispanic black 15.8 (13.7–18.0) 3.9 (3.5–4.3) 1.8 (1.5–2.2)
Hispanic 11.6 (9.8–13.6) 2.5 (2.2–2.8) 2.0 (1.6–2.4)
American Indian/Alaska Native 19.1 (14.9–24.2) 5.7 (4.5–7.1) 1.4 (1.0–1.8)
Asian —d 1.8 (1.2–2.8) —d
Non-Hispanic other 19.5 (16.5–22.9) 7.3 (5.4–9.6) 1.1 (0.9–1.5)
Education level
<High school diploma 23.2 (21.2–25.4) 6.3 (5.7–6.8) 1.3 (1.2–1.5)
High school diploma or GED 14.2 (13.3–15.3) 4.7 (4.5–5.0) 1.4 (1.3–1.5)
Some college 13.0 (12.0–14.1) 3.8 (3.6–4.1) 1.6 (1.4–1.7)
College graduate 6.6 (5.8–7.5) 1.9 (1.8–2.1) 1.6 (1.4–1.8)
Employment status
Employed 8.6 (7.9–9.3) 2.6 (2.5–2.8) 1.8 (1.7–2.0)
Unemployed 17.5 (15.2–20.1) 5.3 (4.6–6.1) 1.6 (1.3–2.0)
Retired 11.0 (7.8–15.2) 4.8 (3.4–6.8) 1.3 (1.2–1.4)
Unable to work 28.0 (25.2–30.9) 12.6 (11.4–13.8) 1.3 (1.1–1.4)
Other 11.4 (9.8–13.3) 3.3 (2.8–4.0) 1.6 (1.3–2.1)
Frequent mental distress
Yes 23.2 (21.8–24.6) 9.6 (8.8–10.4) 1.2 (1.0–1.5)
No 10.7 (10.1–11.4) 3.3 (3.2–3.4) 1.5 (1.3–1.6)
Abbreviations: BMI, body mass index, CI, confidence interval; COPD, chronic obstructive pulmonary disease.
a The final unweighted sample size (n = 408,774) was obtained from 486,303 interviewed adults aged ≥18 years and excluded respondents with a missing value
for age, COPD, arthritis, risk behaviors, or health-related quality of life.
b Age-adjusted percentages and 95% CIs were standardized to the 2000 projected US population except among age groups.
c Adjusted prevalence ratio and 95% CIs were obtained from a multivariable logistic regression model including age, sex, race/ethnicity, education, employment
status, risk behaviors (smoking status, excessive alcohol drinking, physical activity, BMI category, sleep duration), and other conditions (frequent mental distress,
frequent physical distress, asthma status, and arthritis status).
d Unreliable estimate because relative standard error was >0.3 or n <50.
(continued on next page)
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Table 2. Age-Adjusted Prevalence and Adjusted Prevalence Ratio of COPD Among Adults Aged ≥18, by Arthritis Status and Selected Characteristics, Behavioral Risk
Factor Surveillance System, 2016a
Characteristic Has Arthritis, % (95% CI)b
Does Not Have Arthritis, % (95%
CI)b
Adjusted Prevalence Ratio (95%
CI)c
Frequent physical distress
Yes 23.6 (22.1–25.1) 11.5 (10.7–12.3) 1.2 (1.1–1.3)
No 9.6 (9.0–10.3) 3.1 (2.9–3.2) 1.6 (1.5–1.7)
Leisure-time physical activity in the past 30 days
Yes 11.2 (10.5–11.9) 3.0 (2.9–3.2) 1.5 (1.4–1.6)
No 18.8 (17.5–20.2) 6.2 (5.9–6.6) 1.3 (1.3–1.4)
Smoking status
Current smokers 25.8 (24.4–27.2) 9.7 (9.2–10.2) 1.4 (1.3–1.6)
Former smokers 14.3 (12.3–16.5) 5.1 (4.7–5.4) 1.3 (1.2–1.4)
Never smoked 7.6 (6.9–8.3) 1.7 (1.6–1.9) 1.9 (1.7–2.1)
Short sleep duration (<7 hours in 24-hour period)
Yes 17.7 (16.6–18.7) 4.9 (4.7–5.2) 1.5 (1.4–1.6)
No 9.8 (9.2–10.4) 3.2 (3.1–3.4) 1.4 (1.3–1.5)
BMI, kg/m2
Underweight (<18.5) 23.7 (19.9–27.9) 8.1 (6.8–9.6) 1.2 (1.0–1.5)
Normal weight (18.5–24.9) 12.9 (11.8–14.0) 3.6 (3.4–3.9) 1.5 (1.3–1.6)
Overweight (25.0–29.9) 11.5 (10.4–12.7) 3.4 (3.2–3.6) 1.5 (1.3–1.6)
Obese (≥30.0) 15.3 (14.3–16.5) 4.8 (4.5–5.1) 1.5 (1.3–1.6)
Excessive alcohol drinking
Yes 11.4 (10.5–12.3) 3.4 (3.2–3.6) 1.4 (1.3–1.5)
No 14.4 (13.7–15.2) 4.0 (3.9–4.2) 1.7 (1.5–1.8)
Asthma status
Current asthma 34.5 (32.8–36.4) 16.2 (15.4–17.2) 1.3 (1.2–1.4)
History of asthma only 18.8 (16.2–21.6) 8.1 (7.1–9.2) 1.5 (1.2–1.8)
No asthma 8.6 (8.0–9.2) 2.7 (2.6–2.8) 1.5 (1.4–1.6)
Abbreviations: BMI, body mass index, CI, confidence interval; COPD, chronic obstructive pulmonary disease.
a The final unweighted sample size (n = 408,774) was obtained from 486,303 interviewed adults aged ≥18 years and excluded respondents with a missing value
for age, COPD, arthritis, risk behaviors, or health-related quality of life.
b Age-adjusted percentages and 95% CIs were standardized to the 2000 projected US population except among age groups.
c Adjusted prevalence ratio and 95% CIs were obtained from a multivariable logistic regression model including age, sex, race/ethnicity, education, employment
status, risk behaviors (smoking status, excessive alcohol drinking, physical activity, BMI category, sleep duration), and other conditions (frequent mental distress,
frequent physical distress, asthma status, and arthritis status).
d Unreliable estimate because relative standard error was >0.3 or n <50.
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